eMurmur ID vs Tempus ECG-AF

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by eMurmur
VS
by Tempus AI, Inc.

AI Verdict

Tool A, eMurmur ID, focuses on the real-time detection and classification of heart murmurs using electronic stethoscopes, providing immediate decision support for a broad patient population. In contrast, Tool B, Tempus ECG-AF, analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation within the next 12 months. While both are cardiology AI tools, they address different cardiac conditions using distinct diagnostic inputs and serve different clinical decision-making needs.

Choose eMurmur ID if…

Choose eMurmur ID if you need real-time, AI-powered decision support for detecting and classifying heart murmurs directly during a patient encounter using an electronic stethoscope. This tool is ideal for clinicians in primary care or pediatrics who require immediate feedback on auscultation findings to guide further diagnostic steps.

View eMurmur ID →

Choose Tempus ECG-AF if…

Choose Tempus ECG-AF if your objective is to proactively identify patients aged 65 or older, without pre-existing AF, who are at an increased risk of developing new-onset atrial fibrillation within the next 12 months, utilizing existing 12-lead ECG recordings. This solution is best suited for cardiology, geriatrics, or internal medicine practices focused on predictive screening for AF risk to enable earlier intervention.

View Tempus ECG-AF →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature eMurmur ID Tempus ECG-AF
Pricing Unknown Contact vendor
Deployment Cloud, Mobile, API integration Software solution, integrated into healthcare facility systems with advanced cardiology algorithms.
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Yes AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

eMurmur ID

eMurmur ID (Tool A) offers a mobile app for recording and displaying heart sounds with real-time feedback, making it highly accessible and directly usable by clinicians at the point of care. Tempus ECG-AF (Tool B) is described as a software solution integrated into healthcare facility systems, which, while efficient for enterprise, may offer less direct, hands-on clinician interaction compared to a mobile application.

Clinical Value

Tie

Both tools provide significant clinical value in cardiology, addressing distinct but critical needs. eMurmur ID offers AI-powered decision support for real-time heart murmur detection and classification, aiding in the diagnosis of a common physical finding. Tempus ECG-AF provides predictive risk assessment for atrial fibrillation in an at-risk population, supporting earlier identification and follow-up. Both are FDA-cleared, indicating validated clinical utility.

Pricing & Value

Tempus ECG-AF

Tempus ECG-AF (Tool B) explicitly mentions CMS reimbursement availability (CPT 0764T and CPT 0765T to APC 5734, Medicare rate of $128.90), which significantly enhances its financial viability and value proposition for healthcare providers. eMurmur ID (Tool A) only states 'contact vendor' for pricing information, offering no public transparency on potential reimbursement or cost-effectiveness.

Enterprise Readiness

eMurmur ID

eMurmur ID (Tool A) offers flexible deployment options including mobile, cloud (SaaS), on-premise, and hybrid, allowing it to adapt to various IT infrastructures within an enterprise. Both tools are FDA-cleared, HIPAA compliant, and offer BAA, but Tool A's broader deployment flexibility gives it an edge in accommodating diverse enterprise environments.

Innovation

Tie

Both tools demonstrate significant innovation in applying AI to cardiology. eMurmur ID innovatively brings AI to the traditional auscultation process, providing real-time decision support for heart murmur detection. Tempus ECG-AF leverages AI for predictive risk assessment of future atrial fibrillation from standard ECGs, which is a novel approach to proactive patient management.

Support & Docs

Tie

The provided structured facts and web search results do not offer sufficient specific details regarding the depth, breadth, or accessibility of support and documentation for either eMurmur ID or Tempus ECG-AF. While Tempus provides a support email and phone number, there is no comparable detailed information for eMurmur ID to make a definitive distinction.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature eMurmur ID Tempus ECG-AF
Primary Function AI-powered mobile and cloud solution for detecting and classifying heart murmurs, providing decision support for healthcare providers. AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months.
Key Detections Identifies pathologic and innocent heart murmurs, absence of murmur, S1, S2 heart sounds. Detects signs associated with new onset Atrial Fibrillation (AF) within 12 months.
Input Data / Hardware Operates with 3rd party electronic stethoscopes (e.g., Littmann 3200, Thinklabs One) via a mobile app for recording. Analyzes 12-lead ECG recordings; compatible with FDA authorized resting 12-lead ECGs from GE Medical Systems and Philips Medical Systems.
Target Patient Population / Use Case Decision support for healthcare providers in detecting and classifying heart murmurs. No specific age restriction mentioned. Intended for patients 65 years or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery.
Key Specialties Cardiology, Family Medicine, Pediatrics Cardiology, Geriatrics, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring eMurmur ID and Tempus ECG-AF.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

eMurmur ID is designed for detecting and classifying heart murmurs, including pathologic and innocent murmurs, as well as identifying S1 and S2 heart sounds. Tempus ECG-AF analyzes 12-lead ECGs to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months.
eMurmur ID operates with heart sounds recorded using third-party electronic stethoscopes. Tempus ECG-AF requires 12-lead ECG recordings, specifically compatible with FDA authorized resting 12-lead ECGs from GE Medical Systems and Philips Medical Systems.
eMurmur ID is applicable across various specialties including Cardiology, Family Medicine, and Pediatrics for murmur detection. Tempus ECG-AF is specifically intended for patients aged 65 or older who do not have pre-existing AF, pacemakers, ICDs, or recent cardiac surgery.
eMurmur ID offers mobile and cloud deployment, with options for on-premise and hybrid solutions, and uses a mobile app and web portal. Tempus ECG-AF is a software solution designed to be integrated into healthcare facility systems and existing ECG platforms and EHRs.
CMS reimbursement is available for Tempus ECG-AF, utilizing CPT codes 0764T and 0765T, with a Medicare rate of $128.90 effective January 1, 2025. The provided information for eMurmur ID states to contact the vendor for pricing details.
eMurmur ID requires a third-party electronic stethoscope, such as a Littmann 3200 or Thinklabs One. Tempus ECG-AF is compatible with FDA authorized resting 12-lead ECGs from GE Medical Systems and Philips Medical Systems, implying the need for such ECG machines.
AI Tool Finder
AI-powered search. Results may not be comprehensive.